title: Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload: an update.
authors.forename: Massimo
authors.initials: M
authors.lastname: Franchini
authors.forename: Giorgio
authors.initials: G
authors.lastname: Gandini
authors.forename: Dino
authors.initials: D
authors.lastname: Veneri
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Aprili
mesh_terms: D000368:Aged; D000740:Anemia / Q000097:blood; D003676:Deferoxamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D015203:Reproducibility of Results; D012449:Safety; D016896:Treatment Outcome
chemical_list: D007502:Iron Chelating Agents; D003676:Deferoxamine